Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/23/2012CN101772352B Liquid composition for soft-capsule filling
05/23/2012CN101756942B Oral lung inhalation aerosol powder
05/23/2012CN101756914B Omeprazole sodium frozen powder injection and preparation method thereof
05/23/2012CN101744765B Bulleyaconitine A multivesicular liposome and preparation method thereof
05/23/2012CN101732349B Venenum bufonis nanometer long-circulating liposome and preparation method thereof
05/23/2012CN101732331B Composite of monostalotetrahexosylgangliside and glutamate
05/23/2012CN101716194B Multi-flavor chewable calcium tablets and production process thereof
05/23/2012CN101700349B Liquid hard capsule of Anagex extract and preparation method thereof
05/23/2012CN101697978B Asparagus powder and chewable tablet as well as manufacturing method thereof
05/23/2012CN101670095B Pharmaceutical composition for treating embolism and preparation method thereof
05/23/2012CN101664558B Chitosan-collagen-diprospan slow releasing system, preparation method and application thereof
05/23/2012CN101658494B Huperzine A solid lipid nano particle and preparation method thereof
05/23/2012CN101642573B Chitosan-based hepatic-targeted nano-particle drug delivery system and preparation method thereof
05/23/2012CN101636152B Controlled-release preparation containing cilostazol and process for the preparation thereof
05/23/2012CN101612257B Lowdaphne stringbush flower and leaf extract preparation method and drug for curing liver disease
05/23/2012CN101601664B Therapeutic patch comprising capsaicin and method for preparing the same
05/23/2012CN101554438B Traditional Chinese medicine for curing hemorrhoids
05/23/2012CN101530620B Triphosadenine intercalated houghite membrane and preparation method thereof
05/23/2012CN101496792B Punailuoer or delayed-release preparation of salt thereof and preparation method thereof
05/23/2012CN101486799B Agarose gel microsphere and preparation thereof
05/23/2012CN101480402B Cycloartenyl ferulate composition and method for preparing the same
05/23/2012CN101474323B Ageratum soft capsule and preparation method thereof
05/23/2012CN101467984B Tramadol gel for nose as well as preparation method and application thereof
05/23/2012CN101467967B Double-element solution type preparation for intravenous injection and intracerebral injection
05/23/2012CN101386671B Method for preparing environmental responsibility mesoporous silicon sphere
05/23/2012CN101352428B Solid preparation containing ibuprofen and tranexamic acid
05/23/2012CN101292962B Felodipine controlled release formulation and preparation method thereof
05/23/2012CN101282716B Pharmaceutical composition of pranlukast solid-dispersion with improved initial dissolution rate and the method of preparing the same
05/23/2012CN101257929B Gentisic acid for stabilisig 123-i radiopharmaceuticals
05/23/2012CN101217943B Prolonged release formulation of active principles
05/23/2012CN101209321B Medicament for treating burn and scald
05/23/2012CN101199845B Stable anti-IgE humanized single anti-agent
05/23/2012CN101199505B Verapamil liposome and preparing method thereof
05/23/2012CN101193841B Isoalkane mixture, its preparation and use
05/23/2012CN101176721B Hexamethylmelamine liposome and preparation method thereof
05/23/2012CN101141975B Vegf拮抗剂制剂 Vegf antagonist preparations
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101130575B Chitosan quaternary ammonium salt nano grain with hydrated sheath coating and method for preparing the same
05/23/2012CN101120953B Complete water type thin film coating pre-mixture for traditional Chinese medicine tablets
05/23/2012CN101015697B A local drug-release system and a method of the manufacture thereof
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183338 Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
05/22/2012US8183298 Fatty acid esters, processes for their production and for incorporation into cosmetic and/or pharmaceutical formulations
05/22/2012US8183291 Clear ophthalmic solution comprising latanoprost as active ingredient
05/22/2012US8183230 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
05/22/2012US8183222 Method to inhibit cell growth using oligonucleotides
05/22/2012US8183208 Targeted delivery of drugs for the treatment of viral infections
05/22/2012US8182831 For encapsulating an unstable drug and/or a drug with unpleasant taste, drug entrapped in pores of grains
05/22/2012US8182827 Oil-in-water emulsion composition
05/22/2012US8182824 Ciclesonide-containing sterile aqueous suspension
05/22/2012US8182823 Compositions and methods for the therapy and diagnosis of breast cancer
05/22/2012US8182822 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects
05/22/2012US8182802 Cationic block polymers containing 2-methacyloyloxyethyl-2,1-trimethyl ammonium ethyl phosphate liner salt with DNA; drug delivery
05/22/2012US8182801 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
05/22/2012US8182791 Free-flowing fine particle mixtures comprising carrier particles, active drug particles and stabilizer particles, for respiratory system disorders; medical equipment
05/22/2012CA2716268C Composition and method for irrigation of a prepared dental root canal
05/22/2012CA2632949C Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
05/22/2012CA2536135C Multivitamin syrup for children or young adults
05/22/2012CA2533702C Method for preparing functionalized polymers from polymer alcohols
05/22/2012CA2503722C Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
05/22/2012CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
05/22/2012CA2440884C Transdermal patch for administering fentanyl
05/22/2012CA2399918C Water containing soluble fiber
05/22/2012CA2374964C Process for producing an injectable medicament preparation
05/22/2012CA2371977C Media in the form of complex dispersions, their process of preparation and their uses
05/18/2012WO2012065153A2 Modified immune-modulating particles
05/18/2012WO2012065060A2 Gas-filled microbubbles and systems for gas delivery
05/18/2012WO2012064697A2 Materials presenting notch signaling molecules to control cell behavior
05/18/2012WO2012064087A2 Pharmaceutical composition including polymer microsphere containing anastrozole as active ingredient
05/18/2012WO2012063947A1 Gel sheet comprising lipidic peptide type gelling agent and polymeric compound
05/18/2012WO2012063870A1 Stem cell suspension
05/18/2012WO2012063509A1 Amphipathic liquid crystal compound, micelle, and use of the compound or the micelle
05/18/2012WO2012063257A2 Sustained release compositions
05/18/2012WO2012062904A2 Compositions and methods for the prevention and treatment of cancer
05/18/2012WO2012062835A1 Novel pharmaceutical compositions
05/18/2012WO2012062834A1 Liquid pharmaceutical composition for the treatment of a posterior eye disease
05/18/2012WO2012062804A1 Double-acylated glp-1 derivatives with a linker
05/18/2012WO2012062803A1 Double-acylated glp-1 derivatives
05/18/2012WO2012062777A1 CYCLIC RGD PEPTIDES OF AMINO ACIDS BASED ON THIAZOLES OR OXAZOLES AS SELECTIVE ANTAGONISTS OF THE ALFA ανβ3 INTEGRIN
05/18/2012WO2012062691A1 Pharmaceutical compositions for treating hcv infections
05/18/2012WO2012062094A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012WO2012037687A9 Therapeutic polypeptides and uses thereof
05/18/2012WO2012025873A3 STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
05/18/2012WO2012021715A3 Stable formulations of linaclotide
05/18/2012WO2012008782A3 Use of carbon nanotubes for preventing or treating brain disease
05/18/2012WO2012001494A3 Pharmaceutical compositions comprising paracetamol and process for preparing the same
05/18/2012WO2011161531A9 Pharmaceutical composition containing goserelin for in-situ implant
05/18/2012WO2011147034A8 Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
05/18/2012WO2011128629A3 Lipid-vectored drug compositions
05/18/2012WO2011000801A3 Personal care emulsions comprising waxy materials and organopolysiloxanes
05/18/2012WO2010062688A3 Dosage form for insertion into the mouth
05/18/2012CA2825083A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012CA2817710A1 Compositions and methods for the prevention and treatment of cancer
05/18/2012CA2817223A1 Methods of treating cancer
05/18/2012CA2817219A1 Methods of treating cancer
05/18/2012CA2817172A1 Stem cell suspension
05/18/2012CA2816895A1 Bismuth-containing compounds for modulating properties of biologically active agents
05/18/2012CA2816722A1 Conjugates of an il-2 moiety and a polymer
05/18/2012CA2815689A1 Improved high concentration anti-tnf.alpha. antibody liquid formulations
05/18/2012CA2813851A1 Liquid pharmaceutical composition for the treatment of a posterior eye disease
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 1712